IDYA (ideayabio.com) Koefisien nilai perusahaan marang pendapatan

Simbol resmi perusahaan IDEAYA Biosciences Inc (IDYA)

IDEAYA Biosciences (IDYA) is betting on robust R&D and strategic alliances with pharma behemoths without pursuing mergers. However, geopolitics creates risks of disrupting supply chains for rare reagents. Diversification through targeted therapy for various mutations helps expand the pipeline. This EV/Sales chart captures the market value relative to revenue, where a metric value of 47130.03 determines the current investment potential.

ideayabio.com (IDYA): Multiplikator EV/Sales saka 23.11.2025 nganti 20.11.2026

Rincian metrik keuangan lan pasar IDEAYA Biosciences, Inc. (IDYA)

- indikator valuasi pasar bisnis:
Pambiji fundamental perusahaan:IDEAYA Biosciences IDYA
Sampel barang ideayabio.com

IDEAYA Biosciences (IDYA) developments in synthetic lethality create the potential for establishing premium pricing power in the future, despite the current absence of commercial sales. By analyzing changes in EV/Sales, an investor assesses the business value inclusive of net debt relative to revenue, where a stagnant indicator signals exhausted market momentum and a latent risk of a sharp, volatile price breakout.